DONGGUAN, China, Feb. 28, 2025 /PRNewswire/ -- Fapon Biopharma, a biotech innovator in developing therapeutic antibodies and fusion proteins, is pleased to announce that the U.S. Food and Drug Administration (FDA) has approved the Investigational New Drug (IND) application for FP008, its...
Hence then, the article about fapon biopharma announces fda approval of ind for fp008 a first in class immunotherapy for solid tumors was published today ( ) and is available on PR Newswire ( Middle East ) The editorial team at PressBee has edited and verified it, and it may have been modified, fully republished, or quoted. You can read and follow the updates of this news or article from its original source.
Read More Details
Finally We wish PressBee provided you with enough information of ( Fapon Biopharma Announces FDA Approval of IND for FP008, a First-in-Class Immunotherapy for Solid Tumors )
Also on site :
- UN renews Sudan ceasefire appeal over ‘unimaginable suffering’ of civilians
- Central African Republic election: Who’s running and what’s at stake?
- Israeli forces continue ceasefire violations with attacks across Gaza